IGFBP3 Polyclonal Antibody, RBITC Conjugated
Product Specifications
Background
IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors. Also exhibits IGF-independent antiproliferative and apoptotic effects mediated by its receptor TMEM219/IGFBP-3R.
Synonyms
IBP3; BP-53; Insulin-like growth factor-binding protein 3; IBP-3; IGF-binding protein 3; IGFBP-3; IGFBP3
Gene ID
3486
Swiss Prot
P17936
Cellular Locus
Secreted
Host
Rabbit
Cross Reactivity
Human, Rat
Immunogen
186-292/292
Target
IGFBP3
Clonality
Polyclonal
Isotype
IgG
Conjugation
RBITC
Source
KLH conjugated synthetic peptide derived from human IGFBP3
Applications
WB, IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
570nm/595nm
Concentration
1µg/µl
Dilution
WB (1:300-5000), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
3486
Predicted Cross Reactivity
Mouse
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS9020761-01 0.02 mg (Mammalian-Cell)
Recombinant Human COMM domain-containing protein 5 (COMMD5)
Ask
View Details 
MBS9020761-02 0.1 mg (Mammalian-Cell)
Recombinant Human COMM domain-containing protein 5 (COMMD5)
Ask
View Details MBS9020761-03 1 mg (Mammalian-Cell)
Recombinant Human COMM domain-containing protein 5 (COMMD5)
Ask
View Details 